Prediction of repurposed drugs for treating lung injury in COVID-19

Mostrar otras versiones (1)

Background: Coronavirus disease (COVID-19) is an infectious disease discovered in 2019 and currently in outbreak across the world. Lung injury with severe respiratory failure is the leading cause of death in COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, t...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Bing, Garmire, Lana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468567/
https://www.ncbi.nlm.nih.gov/pubmed/32934806
http://dx.doi.org/10.12688/f1000research.23996.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468567/
https://www.ncbi.nlm.nih.gov/pubmed/32934806
http://dx.doi.org/10.12688/f1000research.23996.2

Ejemplares similares